Recent Posts

Big pharma shouldn’t be too greedy

Intellectual property (IP) is a convenient fiction. It is a right enforced by state power and international agreements, one that’s even more fragile than other forms of property rights since it’s not tangible. We choose to believe this fiction because we also believe that intellectual property adds to general welfare. It permits innovation and growth, and supports writers, artists, inventors ...

Read More »

Data stresses urgency for healthy reopenings

Data that came out last week illustrated three developments that underscore the need for the US to resume healthy reopenings: worrisome Covid-19 infections, hospitalisations and deaths in a growing number of states; the clear and present risk of significant recurring damage to the economy; and the considerable upside of reversing both trends quickly. What is desirable is also feasible, although ...

Read More »

Britain top banks show UK economic weakness

The UK’s biggest banks have come a long way since the financial crisis, when taxpayers had to rescue them to the tune of tens of billions of pounds. They’re certainly stronger, with comfortable capital buffers, as they head into what could be the worst recession in three centuries. But with the future of the economic rebound still far from certain, ...

Read More »
Send this to a friend